Prostaglandin catabolizing enzymes

Prostaglandins and Other Lipid Mediators

Volumn 68-69, Issue , 2002, Pages 483-493

  Tai, Hsin Hsiung ^a   Ensor, Charles Mark ^a   Tong, Min ^a   Zhou, Huiping ^a   Yan, Fengxiang ^a  

^a University of Kentucky   (United States)

Author keywords

Aldo keto; Prostaglandins; Reductases; Short chain dehydrogenases; Thromboxane

Indexed keywords

11 HYDROXYTHROMBOXANE B2 DEHYDROGENASE; 11 OXOTHROMBOXANE B2; 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 15 OXOPROSTAGLANDIN 13 REDUCTASE; ICOSANOID; LEUKOTRIENE B4 12 HYDROXYDEHYDROGENASE; OXIDOREDUCTASE; PROSTAGLANDIN; THROMBOXANE B2; UNCLASSIFIED DRUG; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; ALCOHOL DEHYDROGENASE; THROMBOXANE DEHYDROGENASE;

ARTICLE; CATABOLISM; CATALYSIS; CHEMICAL BOND; CIRCULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; LIPOGENESIS; NONHUMAN; OXIDATION; PROSTAGLANDIN METABOLISM; REDUCTION; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; REVIEW; STRUCTURE ACTIVITY RELATION;

15-OXOPROSTAGLANDIN 13-REDUCTASE; ALCOHOL OXIDOREDUCTASES; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; PROSTAGLANDINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036669590     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00050-3     Document Type: Article

References (74)

1. 1. Acta Physiol. Scand. 66:1966;509-510.
2. +-linked 15-hydroxy-prostaglandin dehydrogenases. Prostaglandins. 18:1979;241-246.
3. +-linked 15-hydroxyprostagalndin dehydrogenase activities and studies of their inhibition. Biochem. Biophys. Res. Commun. 81:1978;1227-1233.
4. Chang D., Tai H.H. Prostaglandin 9-ketoreductase and type II 15-hydroxyprostaglandin dehydrogenase are alternate activities of a single enzyme protein. Biochem. Biophys. Res. Commun. 99:1981;745-751.
5. Wermuth B. Purification and properties of an NADPH-dependent carbonyl reductase from human brain: relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase. J. Biol. Chem. 256:1981;1206-1214.
6. 13-reductase in rtissues of the swine. Acta Physiol. Scand. 81:1971;396-404.
7. 4 12-hydroxydehydrogenase. J. Biol. Chem. 268:1993;18128-18135.
8. Yokomizo T., Ogawa Y., Uozumi N., Kume K., Izumi T., Shimizu T. cDNA cloning, expression and mutagenesis study of leukotriene B4 12-hydroxydehydrogenase. J. Biol. Chem. 271:1996;2844-2850.
9. 2 radioimmunoassay to enzyme assay. Biochim. Biophys. Acta. 1036:1990;55-63.
10. 2 in plasma and urine. Anal. Biochem. 164:1987;156-163.
11. 2 as a parameter of thromboxane production. Prostaglandins. 31:1986;413-443.
12. 2 formation in the human circulation. Proc. Natl. Acad. Sci. U.S.A. 83:1986;5861-5865.
13. Ensor C.M., Tai H.H. 15-Hydroxyprostaglandin dehydrogenase. J. Lipid Mediat. Cell Signalling. 12:1995;313-319.
14. Hohl W., Stahl B., Mundkowski R., Hofmann U., Meese C., Kuhlmann U.et al. Mass determination of 15-hydroxyprostaglandin acid as substrate dehydrogenase from human placenta and kinetic studies with (5Z, 8E, 10E, 12S)-12-hydroxy-5,8,10-heptadecatrienoic. Eur. J. Biochem. 214:1993;67-73.
15. 3H ]prostaglandins and their use in the development of a single and sensitive assay for 15-hydroxyprostaglandin dehydrogenase Biochemistry. 15:1976;4586-4592.
16. 1 by guinea pig lung 15-hydroxyprostaglandin dehydrogenase. Biochem. Biophys. Res. Commun. 66:1975;255-261.
17. +-linked 15-hydroxyprostaglandin dehydrogenase. Arch. Biochem. Biophys. 292:1992;239-243.
18. Jez J.M., Bennett M.J., Schlegel B.P., Lewis M., Penning T.M. Comparative anatomy of the aldo-keto reductase superfamily. Biochem. J. 126:1997;625-636.
19. +-dependent 15-hydroxyprostaglandin from porcine kidney. II. Kinetic studies. Biochim. Biophys. Acta. 614:1980;14-24.
20. +-dependent 15-hydroxyprostaglandin dehydrogenase from porcine kidney. Biochim. Biophys. Acta. 1035:1990;190-196.
21. Fujimoto S.S., Okano H.E., Yamamoto Y., Fujita T. Effect of metal ions on 15-hydroxyprostaglandin dehydrogenase activity in rabbit kidney cortex. Prostaglandins. 40:1990;507-514.
22. Hansen H.S. 15-Hydroxyprostaglandin dehydrogenase. Prostaglandins. 12:1976;647-679.
23. Fujimoto Y., Sakuma S., Komatsu S., Sato D., Nishida H., Xiao Y.Q.et al. Inhibition of 15-hydroxyprostaglandin dehydrogenase activity in rabbit gastric antral mucosa by panaxynol isolated from oriental medicines. J. Pharm. Pharmacol. 50:1998;1075-1078.
24. Iijima Y., Kawakita N., Yamazaki M. Inhibition of 15-hydroxyprostaglandin dehydrogenase by anti-allergic agents. Biochem. Biophys. Res. Commun. 93:1980;912-918.
25. +-dependent 15-hydroxyprostaglandin dehydrogenase from gastric mucosa. Life Sci. 43:1988;1647-1652.
26. Berry C.N., Hoult J.R.S., Phillips J.A., McCarthy T.M., Agback H. Highly potent inhibition of prostaglandin 15-hydroxydehydrogenase in vitro and of prostaglandin inactivation in perfused lung by the new azobenzene analogue Ph Cl 28A. J. Pharm. Pharmacol. 37:1985;622-628.
27. Ensor C.M., Zhang H.X., Tai H.H. Purification, cDNA cloning and expression of 15-ketoprostaglandin 13-reductase from porcine lung. Biochem. J. 330:1998;103-108.
28. Nagai K., Tanaka T., Tsuruta K., Mori N. Regulation of placental 15-hydroxyprostaglandin dehydrogenase activity by obstetric drugs. Prostaglandins Leukot. Med. 29:1987;165-173.
29. +-dependent 15-hydroxyprostaglandin dehydrogenase by acrolein. Biochem. Pharmacol. 34:1985;4275-4278.
30. Iijima Y., Ueno T., Sasagawa K., Yamazaki M. Inhibition of 15-hydroxyprostaglandin dehydrogenase by papaverine. Biochem. Biophys. Res. Commun. 80:1978;484-489.
31. +-dependent 15-hydroxyprostaglandin dehydrogenase from swine kidney. I. Purification and partial characterization. Biochim. Biophys. Acta. 614:1980;1-13.
32. Tai H.H., Hollander C.S. Regulation of prostaglandin metabolism: activation of 15-hydroxyprostglandin dehydrogenase by chlorpromazine and imipramine related drugs. Biochem. Biophys. Res. Commun. 68:1976;814-820.
33. +-linked 15-hydroxyprostaglandin dehydrogenase. The primary structure reveals the enzyme belongs to the short-chain alcohol dehydrogenase family. Biochemistry. 29:1990;738-743.
34. +-dependent 15-hydroxyprostaglandin dehydrogenase. J. Biol. Chem. 265:1990;14888-14891.
35. +-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim. Biophys. Acta. 1309:1996;21-24.
36. +-dependent 15-hydroxyprostaglandin dehydrogenase. Gene. 188:1997;41-44.
37. 2α secretion in cultured endometrial cells. Endocrinology. 138:1997;237-247.
38. +-dependent 15-Hydroxyprostaglandin Dehydrogenase. GenBank access number CAA11017, in press.
39. +-dependent 15-hydroxyprostaglanidn dehydrogenase gene. Biochem. Biophys. Res. Commun. 235:1997;582-586.
40. +-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone. Endocrinology. 141:2000;581-597.
41. Pichaud F., Delage-Mourroux R., Pidoux E., Jullienne A., Rousseau-Merck M.F. Chromosomal localization of the type I 15-PGDH gene to 4q34-q35. Hum. Genet. 99:1997;279-281.
42. +-dependent 15-hydroxyprostaglandin dehydrogenase. Gene. 162:1995;319-322.
43. Delage-Mourroux R., Pichaud F., Frendo J.L., Pidoux E., Guliana J.M., Moukhtar M.S.et al. Cloning and sequencing of a new 15-hydroxyprostaglandin dehydrogenase related mRNA. Gene. 188:1997;143-148.
44. +-dependent 15-hydroxyprostaglandin dehydrogenase yields an catalytically inactive enzyme. Biochem. Biophys. Res. Commun. 176:1991;840-845.
45. +-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim. Biophys. Acta. 1208:1994;151-156.
46. Jornvall H.H., Persson B., Krook M., Atrian S., Gonzalez-Duarte R., Jeffery J.et al. Short-chain dehydrogenases/reductases. Biochemistry. 34:1995;6003-6013.
47. +: identification of a peptide in the adenine ring binding domain J. Biol. Chem. 268:1993;16437-16442.
48. +-dependent enzyme (carbonyl reductase). FEBS Lett. 322:1993;139-142.
49. +-dependent 15-hydroxyprostaglandin dehydrogenase to an alanine residue results in an inactive enzyme. Biochem. Biophys. Res. Commun. 220:1996;330-333.
50. +-linked 15-hydroxyprostaglandin dehydrogenase. Adv Exp Med Biol, in press.
51. +-dependent 15-hydroxyprostaglandin dehydrogenase. Biochem. Biophys. Res. Commun. 257:1999;414-417.
52. + during catalysis. Prostagl Leukotri Essent Fatty Acids 2002; (in press).
53. +-dependent 15-hydroxyprostaglandin dehydroegnase (15-PGDH). Arch. Biochem. Biophys. 333:1996;117-120.
54. +-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates. Eur. J. Biochem. 268:2001;3368-3374.
55. Bohren K.M., Grimshaw C.E., Gabbay K.H. Catalytic effectiveness of human aldose reductase. Critical role of C-terminal domain. J. Biol. Chem. 267:1992;20965-20970.
56. Barski O.A., Gabbay K.H., Bohren K.M. The C-terminal loop of aldehyde reductase determines the substrate and inhibitor specificity. Biochemistry. 35:1996;14276-14280.
57. +-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-depedent prostaglandin omega-hydroxylase. Crit. Rev. Biochem. Mol. Biol. 31:1996;101-126.
58. Agins A.P., Thomas J.J., Edmunds C.G., McClosky J.A. Identification of 12-keto-5,8,10-heptadecatrienoic acid as an arachidonic acid metabolite produced by human HL-60 leukemia cells. Biochem. Pharmacol. 36:1987;1799-1805.
59. +-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic (HL-60) cells by phorbol ester. Biochem. J. 279:1991a;553-558.
60. +-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells. Biochem. Biophys. Res. Commun. 177:1991;1258-1265.
61. +-dependent 15-hydroxyprostaglandin dehydrogenase in human neonatal monocytes. Blood. 89:1997;2105-2112.
62. +-dependent 15-hydroxyprostaglandin dehydrogenase by phorbol ester in human promonocytic U937 cells. Biochim. Biophys. Acta. 11497:2000;61-68.
63. Serhan C.N. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity. Prostaglandins. 53:1997;107-137.
64. +-dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and chorion trophoblast cells. J. Clin. Endocrinol. Metab. 84:1999;4645-4651.
65. Celis J.E., Ostergaard M., Basse B., Celis A., Lauridsen J.B., Ratz G.P.et al. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progress of human bladder transitional cell carcinomas. Cancer Res. 56:1996;4782-4790.
66. Frenkian M.m., Segond N., Pidoux E., Cohen R., Jullienne A. Indomethacin, a COX inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation. Prostaglandins. 65:2001;11-20.
67. +-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. Biochem. Biophys. Res. Commun. 276:2000;77-81.
68. Hansen H. 15-Hydroxyprostaglandin dehydrogenase. A review. Prostaglandins. 12:1974;647-649.
69. Ensor C.M., Zhang H.X., Tai H.H. Purification cDNA cloning and expression of 15-ketoprostaglandin 13-reductase from porcine lung. Biochem. J. 330:1998;103-108.
70. 13 reductases. Prostaglandins. 52:1996;35-49.
71. 4 12-hydroxydehydrogenase: implications for chemoprevention. Carcinogenesis. 19:1998;999-1005.
72. 2 in man: identification of twenty urinary metabolites. J. Biol. Chem. 256:1981;8384-8393.
73. 2 in the monkey. J. Biol. Chem. 256:1981;5305-5318.
74. 2 dehydrogenase from porcine kidney. Eur. J. Biochem. 212:1993;403-409.